FDA Application
-
NDC Search Results on Active Ingredient: codeine
Click on Active Ingredient to view the label.
| Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
|---|---|---|---|---|---|
| CODEINE PHOSPHATE; GUAIFENESIN | 69315-248-12 | Leading Pharma, LLC | part341 | HUMAN OTC DRUG | OTC monograph final |
| CODEINE PHOSPHATE; GUAIFENESIN | 0682-0475-16 | Marnel Pharmaceuticals, LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
| GUAIFENESIN; CODEINE PHOSPHATE | 50090-6435-0 | A-S Medication Solutions | part341 | HUMAN OTC DRUG | OTC MONOGRAPH FINAL |
| GUAIFENESIN; CODEINE PHOSPHATE | 70156-112-04 | Noble Pharmaceuticals, LLC | part341 | HUMAN OTC DRUG | OTC MONOGRAPH FINAL |
| CODEINE PHOSPHATE; GUAIFENESIN | 0121-1550-40 | PAI Holdings, LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
| CODEINE PHOSPHATE; GUAIFENESIN | 0121-1550-10 | PAI Holdings, LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
| GUAIFENESIN; CODEINE PHOSPHATE | 68071-2472-4 | NuCare Pharmaceuticals,Inc. | part341 | HUMAN OTC DRUG | OTC monograph final |
| GUAIFENESIN; CODEINE PHOSPHATE | 68071-1350-4 | NuCare Pharmaceuticals,Inc. | part341 | HUMAN OTC DRUG | OTC monograph final |
| PSEUDOEPHEDRINE HYDROCHLORIDE; CODEINE PHOSPHATE | 60575-515-16 | Respa Pharmaceuticals, Inc | part341 | HUMAN OTC DRUG | OTC monograph final |
| PSEUDOEPHEDRINE HYDROCHLORIDE; CODEINE PHOSPHATE; GUAIFENESIN | 54859-520-16 | Llorens Pharmaceutical International Division | part341 | HUMAN OTC DRUG | OTC monograph final |
| CODEINE PHOSPHATE; CHLORPHENIRAMINE MALEATE | 60575-212-16 | Respa Pharmaceuticals, Inc | part341 | HUMAN OTC DRUG | OTC monograph final |
| GUAIFENESIN; CODEINE PHOSPHATE | 17856-0273-1 | ATLANTIC BIOLOGICALS CORP. | part341 | HUMAN OTC DRUG | OTC MONOGRAPH FINAL |
| GUAIFENESIN; CODEINE PHOSPHATE | 57963-103-04 | The Generic Pharmaceutical Company | part341 | HUMAN OTC DRUG | OTC MONOGRAPH FINAL |
| GUAIFENESIN; CODEINE PHOSPHATE | 68071-2935-4 | NuCare Pharmaceuticals,Inc. | part341 | HUMAN OTC DRUG | OTC monograph final |
| CODEINE PHOSPHATE; GUAIFENESIN | 50090-1428-0 | A-S Medication Solutions | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
| CODEINE PHOSPHATE; CHLORPHENIRAMINE MALEATE | 43378-104-08 | codaDOSE Incorporated | part341 | HUMAN OTC DRUG | OTC monograph final |
| CODEINE PHOSPHATE; GUAIFENESIN | 0121-1550-00 | PAI Holdings, LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
| GUAIFENESIN; CODEINE PHOSPHATE | 50383-087-07 | Akorn Operating Company LLC | part341 | HUMAN OTC DRUG | OTC monograph final |
| CODEINE PHOSPHATE; GUAIFENESIN | 55154-5791-5 | Cardinal Health 107, LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
| CODEINE PHOSPHATE; GUAIFENESIN | 23359-040-16 | Centurion Labs, LLC | part341 | HUMAN OTC DRUG | OTC monograph final |
| CODEINE PHOSPHATE; GUAIFENESIN | 12634-969-04 | Apotheca, Inc | part341 | HUMAN OTC DRUG | OTC monograph final |
| CODEINE PHOSPHATE; GUAIFENESIN | 61919-110-04 | DirectRX | part341 | HUMAN OTC DRUG | OTC monograph final |
| CODEINE PHOSPHATE; GUAIFENESIN | 0121-1775-40 | PAI Holdings, LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
| PHENYLEPHRINE HYDROCHLORIDE; DEXCHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE | 66594-499-01 | Pro-Pharma, LLC | part341 | HUMAN OTC DRUG | OTC monograph final |
| GUAIFENESIN; CODEINE PHOSPHATE | 50383-087-04 | Akorn Operating Company LLC | part341 | HUMAN OTC DRUG | OTC monograph final |
| GUAIFENESIN; CODEINE PHOSPHATE | 57963-103-16 | The Generic Pharmaceutical Company | part341 | HUMAN OTC DRUG | OTC MONOGRAPH FINAL |
| GUAIFENESIN; CODEINE PHOSPHATE | 54932-208-81 | BioRamo, LLC | part341 | HUMAN OTC DRUG | OTC MONOGRAPH FINAL |
| CODEINE PHOSPHATE; GUAIFENESIN | 0121-0775-16 | PAI Holdings, LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
| BROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE; CODEINE PHOSPHATE | 50991-723-15 | Poly Pharmaceuticals, Inc. | HUMAN OTC DRUG | unapproved drug other | |
| CODEINE PHOSPHATE; GUAIFENESIN | 70752-177-12 | QUAGEN PHARMACEUTICALS LLC | part341 | HUMAN OTC DRUG | OTC monograph final |
| 1-30 | 31-60 | 61-90 | 91-120 | 121-150 | 151-180 | 181-210 | 211-240 | 241-270 | 271-300 |
| 301-330 | 331-360 | 361-390 | 391-420 | 421-450 | 451-480 | 481-510 | 511-540 | 541-570 | 571-600 |
| 601-630 | 631-660 | 661-690 | 691-720 | 721-750 | 751-763 |
-
